Skip to main page content

Carol Tadrous, MD

Uczestniczy w 5 elementy

Elementy, w których Carol Tadrous, MD uczestniczy

niedziela 22 czerwiec, 2025

Strefa czasowa: (GMT-05:00) Eastern Time (US & Canada)
11:15
11:15 - 12:45 | 1 godz. 30 min.
Uveitis

Learning ObjectivesAt the end of this session, participants will be able to:Assess uveitis guidelines to determine when referral to a uveitis specialist or rheumatologist for immunomodulatory treatment is necessary to prevent complications.Describe a new cl...

14:00
14:00 - 15:30 | 1 godz. 30 min.
Uveitis

Learning ObjectivesAt the end of this session, participants will be able to:Apply uveitis guidelines to the diagnosis and management of scleritis and retinal vasculitis. Assess the impact of age on ...

Elementy, w których Carol Tadrous, MD attends

sobota 17 czerwiec, 2023

Strefa czasowa: (GMT-05:00) Eastern Time (US & Canada)
10:45
10:45 - 12:15 | 1 godz. 30 min.
Cataract

 Learning Objectives: At the end of this session, participants will be able to: Enhance surgical strategies for routine cataractsDevelop an approach to complex cataract surgery: techniques, strategies, and instrumentationCanMEDS Roles: Medical expert, scholarX

15:45
15:45 - 17:15 | 1 godz. 30 min.
Glaucoma

 Learning ObjectivesAt the end of this session, participants will be able to:Identify common reasons for discrepancy between structure and function evaluations of glaucoma patientsDescribe the difference between glaucomatous and non-glaucomatous abnormalities on glaucoma diagnostic testing

niedziela 18 czerwiec, 2023

Strefa czasowa: (GMT-05:00) Eastern Time (US & Canada)
14:30
14:30 - 14:35 | 5 min.

 Authors: Carol Tadrous , Steven Schendel, Kaivon Vaezi, Kulbir S. Gill, Mahadev Bhalla, Derek Chan, Claudio Perez. University of British Columbia. Author Disclosures: C. Tadrous: None. S. Schendel: Any direct financial payments including receipt of honoraria; Name of for-profit or not-for-profit organization(s); Abbvie, Alcon, Glaukos, Labtician, Thea, Bausch and Lomb. Any direct financial payments...